New, cheaper anti-malaria drugs next year

12/13/2005 | NYTimes.com

A public-private partnership says new, cheaper malaria pills, which combine forms of artemisinin with either amodiaquine or mefloquine, will become available next year, allowing patients to take fewer pills while still ensuring they get the wider range of drugs needed. Sanofi-Aventis has agreed to make the amodiaquine combination and Brazil's Far-Manguinhos will make the mefloquine one.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health